Benten BioServices

Benten BioServices was a private U.S. contract services organization serving biotechnology and pharmaceutical customers with regulatory-compliant biologics testing and biomanufacturing services. The company focused on biological safety testing, raw material testing, assay and process validation, cell banking and characterization, and related development support for biopharmaceutical products. Public company-profile sources also describe capabilities in early-stage manufacturing for vaccines and cellular therapies. Benten BioServices was acquired by Deltagen on December 10, 2009, and later sources describe it as closed rather than operating as an independent company.